SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

PLoS One. 2022;17(6):e0269911.

Augmented risk of dementia in hypertrophic cardiomyopathy: A propensity score matching analysis using the nationwide cohort.

, , , , , , , , , ,

제1저자 이희선 · 교신저자 김형관

소속 (5)
  1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  2. Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Korea.
  3. Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
  4. Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea.
  5. Department of Cardiology, Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea.

Abstract

BACKGROUND Dementia is a big medical and socioeconomic problem on aging society, and cardiac diseases have already shown a significant contribution to developing dementia. However, the risk of dementia related to hypertrophic cardiomyopathy (HCM), the most common inherited cardiomyopathy, has never been evaluated.

METHODS In a large-scale longitudinal cohort using National Health Insurance database, 4,645 subjects with HCM aged ≥50 years between 2010 and 2016 were collected and matched with 13,935 controls, based on propensity scores (1:3). We investigated the incidence and risk of dementia, Alzheimer's disease (AD), and vascular dementia (VaD) between groups.

RESULTS During follow-up (median 3.9 years after 1-year lag), incident dementia occurred in 739 subjects (4.0%): 78.2% for AD and 13.0% for VaD. The incidence of dementia, AD, and VaD were 23.0, 18.0, and 2.9/1,000 person-years, respectively, and was generally more prevalent in HCM. HCM group had a 50% increased risk of dementia, particularly AD, whereas there was no difference in the risk of VaD. The impact of HCM on AD (HR 1.52, 95% CI 1.26-1.84, p<0.001) was comparable with that of diabetes mellitus and smoking. Increased risk of AD in relation to HCM was consistent in various subgroups including younger healthier population.

CONCLUSIONS This is the first to demonstrate the increased risk of dementia, mainly AD rather than VaD, in subjects with HCM. Early surveillance and active prevention for cognitive impairment could help for a better quality of life in an era that HCM is considered a chronic manageable disease with low mortality.

Figures

Fig 1
Fig 1 Schematic flow of the study population. AF, atrial fibrillation; HCM, hypertrophic cardiomyopathy; HF, heart failure; MI, myocardial infarction.
Fig 2
Fig 2 Comparison of incidence rates of any dementia, AD, and VaD according to age and sex. Generally, incidence rate of dementia was higher in patients with HCM than that in controls: AD was significantly frequent, whereas VaD did not have statistical significance. In age- and sex-stratified analyses, the incidence of dementia was higher in the elderly and women, regardless of dementia type. A consistent trend was found to have a higher incidence of any dementia and AD but a similar incidence of VaD in the HCM group. AD, Alzheimer’s disease, VaD, vascular disease, other abbreviation as Fig 1.
Fig 3
Fig 3 Kaplan-Meier curves for incidence probability of any dementia, AD, and VaD. The incidence probability of any type of dementia (A) and AD (B) tended to increase in patients with HCM, compared with controls. However, there was no significant differences in the incidence probability of VaD (C) the two groups. Abbreviations as Figs 1 and 2.
Fig 4
Fig 4 Subgroup analysis regarding the risk of AD by HCM. HCM showed a consistent tendency to increase the risk of any type of dementia (A) and AD (B), in almost all subgroups stratified by age, life behavior, and comorbidity. In particular, subgroups that were deemed low risk for dementia demonstrated a high risk for developing AD by HCM, suggesting the direct impact of HCM on cognitive dysfunction. On the other hand, the risk of VaD did not show a significant increase in all subgroups except for the subgroup without a history of MI. BMI, body mass index; CI, confidence interval; other abbreviations as Figs 1 and 2.

그림 출처: PubMed Central 공개 논문 (PMC9202937)

Conflict of interest statement

The authors have declared that no competing interests exist.

그 밖의 정보
출판 형태
Journal Article, Research Support, Non-U.S. Gov't
저널
PloS one · eISSN 1932-6203
전자 출판
2022-06-16
MeSH
Alzheimer Disease* / epidemiology · Cardiomyopathy, Hypertrophic* / complications / epidemiology · Cohort Studies · Dementia, Vascular* / epidemiology · Humans · Incidence · Propensity Score · Quality of Life · Risk Factors
참고문헌
41편